Kimberly-Clark에 대한 매도 수량은 투자자에게 Kimberly-Clark의 주식 하락에 베팅하는 정도를 알려줍니다. 매도 수량 데이터는 2주마다 업데이트됩니다.

Kimberly-Clark (NYSE:KMB) 주식, 공매도 수량 보고

Kimberly-Clark

With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.

Equities

News

Previews

Tech

Trading Ideas

ABBV

AGYS

ASML

BJRI

CHKP

CHTR

CMCSA

DECK

GATX

GOOG

GOOGL

JNPR

NFLX

NXPI

ODFL

ORLY

SKYW

SPOT

TSLA

VRSN

S&amp;P 500 기업들 중 약 14%가 6월 분기 실적을 발표했으며, 더 넓은 지수를 구성하는 기업들의 혼합 실적 성장률은 여전히 ​​양호하다. 이번 주에는 기술 보고 시즌이 공식적으로 시작될 것이며, 이는 최근 주에 가파른 하락세를 보인 시장의 향방을 잠재적으로 결정할 수 있다.

테슬라, 알파벳, GM 및 포드가 이번 주 실적 발표 주도하며 상승세 유지 위해 고군분투

Kimberly-Clark Corp

KAMBI GROUP LTD ORD B by Kambi Group LTD.

Kambi Group PLC

Costco Wholesale Corp. is switching manufacturers for its popular Kirkland Signature brand of diapers as its supplier moves away from store brands to boost profitability.&nbsp;
&nbsp;
<a href="https://www.bloomberg.com/news/articles/2024-12-09/costco-s-cost-popular-kirkland-baby-diapers-are-getting-a-new-supplier?embedded-checkout=true" title="https://www.bloomberg.com/news/articles/2024-12-09/costco-s-cost-popular-kirkland-baby-diapers-are-getting-a-new-supplier?embedded-checkout=true">https://www.bloomberg.com/news/articles/2024-12-09/costco-s-cost-popular-kirkland-baby-diapers-are-getting-a-new-supplier?embedded-checkout=true</a>

COST

'Costco's Popular Kirkland Baby Diapers Are Shifting Suppliers' - Bloomberg

RBC Capital analyst Nik Modi reiterates Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Outperform and maintains $165 price target.

Price Target

Reiteration

Analyst Ratings

RBC Capital Reiterates Outperform on Kimberly-Clark, Maintains $165 Price Target

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and lowers the price target from $142 to $140.

JP Morgan Maintains Underweight on Kimberly-Clark, Lowers Price Target to $140

UBS analyst Peter Grom maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Neutral and lowers the price target from $153 to $151.

UBS Maintains Neutral on Kimberly-Clark, Lowers Price Target to $151

Goldman Sachs analyst Bonnie Herzog reiterated the Buy rating on Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) stock, <a target="_blank" href="https://www.benzinga.com/quote/KMB/analyst-ratings" rel="noreferrer noopener">with a price forecast of $152.</a>
The company reported third quarter adjusted earnings per share of $1.83, beating the street view of $1.70. Quarterly revenues of $4.952 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41446271/kimberly-clark-announces-third-quarter-2024-results-and-reaffirms-2024-profit-outlook" rel="noreferrer noopener"> missed the analyst consensus of $5.048 billion.</a>
According to Herzog, Kimberly-Clark&#8217;s management efforts on productivity and the current environment are conducive to margin expansion.
The analyst projects that the market underestimates the company&#8217;s potential for gross margin growth, which should lead to healthy EPS growth despite increased reinvestments.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41453793/retail-inventory-pressures-hit-kimberly-clarks-annual-outlook-stock-slides" rel="noreferrer noopener">Retail Inventory Pressures Hit Kimberly-Clark&#8217;s Annual Outlook, Stock Slides</a>
Herzog also forecasts that Kimberly-Clark&#8217;s segment reorganization will enhance execution moving forward.
As a result, the analyst sees a favorable risk/reward scenario, with Kimberly-Clark&#8217;s improving fundamentals contrasting sharply with its deep valuation discount compared to its HPC peers, offering an attractive entry point for investors.
The analyst indicated that adjusted EBIT is expected to grow in the mid-to-high teens on a constant currency basis, with adjusted EPS also projected to rise similarly.
For the fourth quarter of 2024, organic sales growth is expected to be about 4% at the mid-point, versus Goldman Sachs&#8217; estimate of 5.0%.
The projected all-in EPS is $1.46, ranging from $1.33 to $1.60, reflecting a constant currency growth of 15% &#8211; 19%, compared to Goldman Sachs&#8217; estimate of $1.60.
Price Action: KMB shares are trading lower by 4.30% to $138.01 at last check Tuesday.
Photo via Shutterstock
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41375637/market-very-convinced-of-a-trump-win-says-stanley-druckenmiller-why-billionaire-inv" target="_blank" rel="noreferrer noopener">Market &#8216;Very Convinced&#8217; Of A Trump Win, Says Stanley Druckenmiller: Why Billionaire Investor Thinks Blue Sweep Is &#8216;Highly Unlikely&#8217;</a></li>
</ul>

Analyst Color

Markets

General

Kimberly-Clark's Growth Potential 'Underestimated,' Analyst Sees Attractive Entry Point

Wall Street traded lower for the second consecutive day on Tuesday, as investor sentiment turned cautious with the U.S. presidential election <a href="https://www.benzinga.com/topic/2024-elections">just two weeks away. </a>
Concerns over U.S. fiscal policies and potential shifts in economic direction fueled the pause in risk-taking.
The International Monetary Fund (IMF) upgraded its U.S. growth forecasts for 2024 and 2025 in the latest World Economic Outlook, while also flagging rising concerns about the country's debt trajectory, warning that with current large fiscal deficits, &#8220;the U.S. public debt is not stabilized.&#8221;
Commodities were the standout performers on Tuesday, with both metals and energy experiencing notable gains.
Gold, tracked by the SPDR Gold Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLD#NYSE">GLD</a>), rose 0.8%, pushing further into record territory. This increase extended its year-to-date performance to 34%, positioning gold for its strongest <a href="https://www.benzinga.com/markets/bonds/24/10/41455678/gold-on-track-for-best-year-since-1979-veteran-investor-says-sell-bonds-buy-gold">annual gain since 1979.</a> Gold miners, as represented by the VanEck Gold Miners ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GDX#NYSE">GDX</a>), rallied for the ninth consecutive session, hitting their highest levels in over four years.
Silver, tracked by the iShares Silver Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SLV#NYSE">SLV</a>), surged 2.8%, reaching levels not seen since October 2012.
Oil prices rallied nearly 3%, building on a 2% surge from Monday. U.S. Treasury yields ticked up modestly on Tuesday following Monday's spike, with the 10-year yield settling at 4.21%.
Meanwhile, the U.S. Dollar Index (DXY), tracked by the Invesco DB USD Index Bullish Fund ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUP#NYSE">UUP</a>), climbed past the 104 mark, continuing its steady ascent and eyeing a fourth consecutive week of gains.
In the cryptocurrency market, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) fell 0.5%, dipping to around $67,000 and marking its second consecutive day of declines.
<h3 class="wp-block-heading">Tuesday&#8217;s Performance In US Major Indices, ETFs</h3>
<figure class="wp-block-table is-style-stripes"> 
<table>
<tbody>
<tr>
<td>Major Indices</td>
<td>Price</td>
<td>1-day %change</td>
</tr>
<tr>
<td>Dow Jones</td>
<td>42,907.57</td>
<td>-0.1 %</td>
</tr>
<tr>
<td>S&amp;P 500</td>
<td>5,840.39</td>
<td>-0.2%</td>
</tr>
<tr>
<td>Nasdaq 100</td>
<td>20,291.15</td>
<td>-0.3%</td>
</tr>
<tr>
<td>Russell 2000</td>
<td>2,228.60</td>
<td>-0.5%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Updated at 12:35 p.m. ET</figcaption></figure>
According to <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent102224&amp;t=be2bearmibe3na1">Benzinga Pro</a> data:
<ul>
<li>The&nbsp;SPDR S&amp;P 500 ETF Trust&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) fell 0.3% to $581.79.</li>
<li>The&nbsp;SPDR Dow Jones Industrial Average&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIA#NYSE">DIA</a>)&nbsp;inched 0.1% lower to $429.14.</li>
<li>The tech-heavy Invesco QQQ Trust Series (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>) fell 0.4% to $493.29.</li>
<li>The iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>) fell 0.5% $221.04.</li>
<li>The Energy Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLE#NYSE">XLE</a>) outperformed, up 0.6%. The Industrial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLI#NYSE">XLI</a>) lagged, down 1.1%.</li>
</ul>
<h3 class="wp-block-heading">Tuesday&#8217;s Stock Performers</h3>
General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) surged 9%, on track for its strongest session in nearly a year, after reporting stronger-than-expected earnings and announcing an additional $5 billion share buyback program extending into next year.
Other stocks reacting to earnings include: 
<ul>
<li>Southern Copper Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCCO#NYSE">SCCO</a>), up 1.5%</li>
<li>Nucor Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NUE#NYSE">NUE</a>), down 6%</li>
<li>W.R. Berkley Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WRB#NYSE">WRB</a>), down 4.6%</li>
<li>Zion Bancorp. N.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZION#NASDAQ">ZION</a>), up 6.8%</li>
<li>Wintrust Financial Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WTFC#NASDAQ">WTFC</a>), up 1.6%</li>
<li>Philip Morris International Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PM#NYSE">PM</a>), up 8.8%</li>
<li>GE Aerospace (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GE#NYSE">GE</a>), down over 8%</li>
<li>Danaher Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DHR#NYSE">DHR</a>), down 3%</li>
<li>Verizon Communications Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VZ#NYSE">VZ</a>), down 4.4%</li>
<li>RTX Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>), down 0.4%</li>
<li>Lockheed Martin Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), down 5.8%</li>
<li>Fiserv Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>), down 0.4%</li>
<li>Moodys Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MCO#NYSE">MCO</a>) down 4.5%</li>
<li>3M Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MMM#NYSE">MMM</a>), down 0.9%</li>
<li>Freeport-McMoran Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FCX#NYSE">FCX</a>), up 1.4%</li>
<li>Kimberly-Clark Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>), down 4%</li>
<li>PulteGroup Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PHM#NYSE">PHM</a>), down 5.7%</li>
</ul>
Large-cap companies reporting earnings after the close include Texas Instruments Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TXN#NASDAQ">TXN</a>), Baker Hughes Co. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKR#NASDAQ">BKR</a>), Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>), Packaging Corporation of America (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKG#NYSE">PKG</a>), Manhattan Associates Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MANH#NASDAQ">MANH</a>), East West Bancorp. Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EWBC#NASDAQ">EWBC</a>) and Enphase Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENPH#NASDAQ">ENPH</a>)
Now Read:
<ul>
<li><a href="https://www.benzinga.com/government/24/10/41455013/how-us-elections-could-impact-us-dollar-goldman-sachs-expects-greenback-will-remain-stronger-for-lon">How US Elections Could Impact US Dollar: Goldman Sachs Expects Greenback Will Remain &#8216;Stronger For Longer&#8217;</a></li>
</ul>
Image: Shutterstock

Earnings

Large Cap

Mid Cap

Sector ETFs

Broad U.S. Equity ETFs

New ETFs

Commodities

Currency ETFs

Small Cap

ETFs

$BTC

SPDR Dow Jones Industrial Average ETF Trust

ENPH

EWBC

Market Vectors ETF Trust Market Vectors Gold Miners

MANH

SCCO

PowerShares DB US Dollar Index Bullish Fund

WTFC

ZION

Stocks Fall, GM Eyes Best Day In A Year, Gold Breaks Records, Silver Hits 12-Year Highs: What's Driving Markets Tuesday?

WIIM

Kimberly-Clark shares are trading lower after the company reported worse-than-expected Q3 revenue results and cut its FY24 organic net sales guidance, citing headwinds from changes in retail inventory levels.

Kimberly-Clark Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) shares are<a target="_blank" href="https://www.benzinga.com/premarket" rel="noreferrer noopener"> trading lower on Tuesday.</a>
The company reported third quarter adjusted earnings per share of $1.83, beating the street view of $1.70. Quarterly revenues of $4.952 billion<a target="_blank" href="https://www.benzinga.com/pressreleases/24/10/n41446271/kimberly-clark-announces-third-quarter-2024-results-and-reaffirms-2024-profit-outlook" rel="noreferrer noopener"> missed the analyst consensus of $5.048 billion.</a>
Quarterly sales were down 4%, with organic sales growth of 1% versus the prior year.
Kimberly-Clark&#8217;s quarterly adjusted gross margin was 36.7%, up 90 basis points versus the prior year, driven by strong gross productivity gains.
The company&#8217;s volume and mix were positive in Developed Markets (representing&nbsp;Australia,&nbsp;South Korea, and Western/Central Europe), offset by a decline in&nbsp;North America,&nbsp;while volumes in Developing and Emerging (D&amp;E) markets were in line with the year-ago period.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/earnings/24/10/41447996/us-stocks-remains-on-edge-ahead-of-flurry-of-earnings-from-lockheed-martin-gm-and-others-this-is-st" rel="noreferrer noopener">US Stocks Remains On Edge Ahead Of Flurry Of Earnings From Lockheed Martin, GM And Others: This Is Still A &#8216;Buy The Dip&#8217; Market, Says Expert</a>
Quarterly adjusted operating profit increased by 5% despite an unfavorable impact of 4 percentage points from currency translation that was primarily driven by hyperinflationary economies.
Excluding currency impacts, growth in adjusted operating profit reflected gross productivity gains, relatively neutral&nbsp;pricing net of cost inflation, supply chain related investments, as well as planned increases in marketing, research and general expenses.
Personal Care sales were $2.6 billion, down 2%, but organic sales in the segment grew 3% due to pricing actions in inflationary markets and better product mix, with volume steady across all markets.
Consumer Tissue sales were $1.5 billion, also down 2%, with segmental organic sales declining by 1%.
KCP sales fell 10% to $767 million due to divestitures and unfavorable currency effects.
The company exited the quarter with cash and equivalents worth $1.11 billion. Inventories as of quarter-end was $1.937 billion.
FY24 Outlook: The company expects organic net sales to grow by 3%-4%, down from a mid-single-digit rate, mainly due to changes in retail inventory levels. Reported net sales will still be negatively affected by 400 basis points from currency translation and 120 basis points from divestitures.
Adjusted operating profit and adjusted earnings per share are expected to grow at a mid-to-high teens percentage rate in constant currency.
Reported operating profit and reported earnings per share are now projected to be negatively impacted by about 650 basis points from currency translation, an improvement from the previous expectation of 700 basis points.
Price Action: KMB shares are trading lower by 5.12% to $136.83 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/10/41445510/tesla-shareholders-demand-answers-from-elon-musk-on-growing-list-of-promises-ahead-of-q3-earning" target="_blank" rel="noreferrer noopener">Tesla Shareholders Demand Answers From Elon Musk On Growing List Of Promises Ahead Of Q3 Earnings: From Affordable Models To FSD Rollout And Next-Generation Roadster</a></li>
</ul>

Guidance

Movers

Retail Inventory Pressures Hit Kimberly-Clark's Annual Outlook, Stock Slides

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) reported quarterly earnings of $1.83 per share which beat the analyst consensus estimate of $1.70 by 7.65 percent. This is a 5.17 percent increase over earnings of $1.74 per share from the same period last year. The company reported quarterly sales of $4.952 billion which missed the analyst consensus estimate of $5.048 billion by 1.89 percent. This is a 3.51 percent decrease over sales of $5.132 billion the same period last year.

Earnings Beats

Earnings Misses

CORRECTION: Kimberly-Clark Q3 2024 Adj. EPS $1.83 Beats $1.70 Estimate, Sales $4.952B Miss $5.048B Estimate

Kimberly-Clark Says Reported Operating Profit And EPS Are Now Expected To Be Negatively Impacted By Approximately 650 Basis Points From Currency Translation Versus A Previous Expectation Of 700 Basis Points

Kimberly-Clark Says Adjusted Operating Profit And Adjusted EPS Are Still Expected To Grow At A Mid-To-High Teens Percentage Rate On A Constant-Currency Basis

Reported Net Sales are still expected to be negatively impacted by 400 basis points of currency translation and 120 basis points from divestitures.

Kimberly-Clark Says 2024 Organic Net Sales Are Expected To Grow Between 3%-4% Versus A Mid-single Digit Rate Previously, Primarily Reflecting Discrete Headwinds From Changes In Retail Inventory Levels

Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) is preparing to release its quarterly earnings on Tuesday, 2024-10-22. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Kimberly-Clark to report an earnings per share (EPS) of $1.70.
The announcement from Kimberly-Clark is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
<h3>Historical Earnings Performance</h3>
The company's EPS beat by $0.25 in the last quarter, leading to a 3.41% increase in the share price on the following day.
Here's a look at Kimberly-Clark's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
<th>Q3 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.71</td>
<td>1.63</td>
<td>1.54</td>
<td>1.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.96</td>
<td>2.01</td>
<td>1.51</td>
<td>1.74</td>
</tr>
<tr>
<td>Price Change %</td>
<td>3.0%</td>
<td>1.0%</td>
<td>2.0%</td>
<td>-1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2024/1729526472_0.png" alt="eps graph" />
<h3>Tracking Kimberly-Clark's Stock Performance</h3>
Shares of Kimberly-Clark were trading at $145.41 as of October 18. Over the last 52-week period, shares are up 19.84%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about Kimberly-Clark</h3>
For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Kimberly-Clark.
The consensus rating for Kimberly-Clark is Neutral, based on 7 analyst ratings. With an average one-year price target of $147.86, there's a potential 1.68% upside.
<h3>Peer Ratings Comparison</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Church &amp; Dwight Co, Clorox and Colgate-Palmolive, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Church &amp; Dwight Co received a Underperform consensus from analysts, with an average 1-year price target of $103.58, implying a potential 28.77% downside.</li>
<li>The prevailing sentiment among analysts is an Neutral trajectory for Clorox, with an average 1-year price target of $152.42, implying a potential 4.82% upside.</li>
<li>The prevailing sentiment among analysts is an Buy trajectory for Colgate-Palmolive, with an average 1-year price target of $108.58, implying a potential 25.33% downside.</li>
</ul>
<h3>Key Findings: Peer Analysis Summary</h3>
The peer analysis summary offers a detailed examination of key metrics for Church &amp; Dwight Co, Clorox and Colgate-Palmolive, providing valuable insights into their respective standings within the industry and their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>Kimberly-Clark</td>
<td>Neutral</td>
<td>-2.05%</td>
<td>$1.81B</td>
<td>49.91%</td>
</tr>
<tr>
<td>Church &amp; Dwight Co</td>
<td>Underperform</td>
<td>3.92%</td>
<td>$712.10M</td>
<td>5.79%</td>
</tr>
<tr>
<td>Clorox</td>
<td>Neutral</td>
<td>-5.75%</td>
<td>$884M</td>
<td>103.10%</td>
</tr>
<tr>
<td>Colgate-Palmolive</td>
<td>Buy</td>
<td>4.89%</td>
<td>$3.07B</td>
<td>414.16%</td>
</tr>
</tbody>
</table>

Key Takeaway:
Kimberly-Clark ranks at the bottom for Revenue Growth among its peers. It is in the middle for Gross Profit. For Return on Equity, Kimberly-Clark is at the top.
<h3>Discovering Kimberly-Clark: A Closer Look</h3>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>Financial Insights: Kimberly-Clark</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Decline in Revenue: Over the 3 months period, Kimberly-Clark faced challenges, resulting in a decline of approximately -2.05% in revenue growth as of 30 June, 2024. This signifies a reduction in the company's top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 10.82% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): Kimberly-Clark's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of 49.91%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Kimberly-Clark's ROA stands out, surpassing industry averages. With an impressive ROA of 3.17%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Kimberly-Clark's debt-to-equity ratio is below the industry average. With a ratio of 7.01, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<a href="https://www.benzinga.com/quote/KMB/earnings">To track all earnings releases for Kimberly-Clark visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

What to Expect from Kimberly-Clark's Earnings

Barclays analyst Lauren Lieberman maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Equal-Weight and raises the price target from $135 to $144.

Barclays Maintains Equal-Weight on Kimberly-Clark, Raises Price Target to $144

8 analysts have shared their evaluations of Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">3</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
The 12-month price targets, analyzed by analysts, offer insights with an average target of $145.12, a high estimate of $165.00, and a low estimate of $134.00. This upward trend is apparent, with the current average reflecting a 3.24% increase from the previous average price target of $140.57.
<img src="https://www.benzinga.com/files/images/story/2024/1728658863_0.png" alt="price target chart" />
<h2>Decoding Analyst Ratings: A Detailed Look</h2>
The analysis of recent analyst actions sheds light on the perception of Kimberly-Clark by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$142.00</td>
<td>$137.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$147.00</td>
<td>$146.00</td>
</tr>
<tr>
<td>Steve Powers</td>
<td>Deutsche Bank</td>
<td>Raises</td>
<td>Hold</td>
<td>$142.00</td>
<td>$139.00</td>
</tr>
<tr>
<td>Nik Modi</td>
<td>RBC Capital</td>
<td>Maintains</td>
<td>Outperform</td>
<td>$165.00</td>
<td>$165.00</td>
</tr>
<tr>
<td>Chris Carey</td>
<td>Wells Fargo</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$134.00</td>
<td>$138.00</td>
</tr>
<tr>
<td>Robert Moskow</td>
<td>TD Cowen</td>
<td>Announces</td>
<td>Buy</td>
<td>$161.00</td>
<td>-</td>
</tr>
<tr>
<td>Andrea Teixeira</td>
<td>JP Morgan</td>
<td>Raises</td>
<td>Underweight</td>
<td>$135.00</td>
<td>$123.00</td>
</tr>
<tr>
<td>Lauren Lieberman</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$135.00</td>
<td>$136.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Kimberly-Clark. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Kimberly-Clark compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Kimberly-Clark's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Kimberly-Clark's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/KMB/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Kimberly-Clark analyst ratings.</a>
<h2>Get to Know Kimberly-Clark Better</h2>
With more than half of sales from personal care and another third from consumer tissue products, Kimberly-Clark sits as a leading manufacturer in the tissue and hygiene realm. Its brand mix includes Huggies, PullUps, Kotex, Depend, Kleenex, and Cottonelle. The firm also operates K-C Professional, which partners with businesses to provide safety and sanitary offerings for the workplace. Kimberly-Clark generates just over of half its sales in North America and more than 10% in Europe, with the rest primarily concentrated in Asia and Latin America.
<h3>A Deep Dive into Kimberly-Clark's Financials</h3>
Market Capitalization Analysis: Below industry benchmarks, the company's market capitalization reflects a smaller scale relative to peers. This could be attributed to factors such as growth expectations or operational capacity.
Negative Revenue Trend: Examining Kimberly-Clark's financials over 3 months reveals challenges. As of 30 June, 2024, the company experienced a decline of approximately -2.05% in revenue growth, reflecting a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Consumer Staples sector.
Net Margin: Kimberly-Clark's net margin excels beyond industry benchmarks, reaching 10.82%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Kimberly-Clark's ROE falls below industry averages, indicating challenges in efficiently using equity capital. With an ROE of 49.91%, the company may face hurdles in generating optimal returns for shareholders.
Return on Assets (ROA): Kimberly-Clark's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 3.17% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 7.01.
<h2>Analyst Ratings: Simplified</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;utm_source=benzinga-insights">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Peeling Back The Layers: Exploring Kimberly-Clark Through Analyst Insights

JP Morgan analyst Andrea Teixeira maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Underweight and raises the price target from $137 to $142.

JP Morgan Maintains Underweight on Kimberly-Clark, Raises Price Target to $142

Deutsche Bank analyst Steve Powers maintains Kimberly-Clark (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMB#NYSE">KMB</a>) with a Hold and raises the price target from $146 to $147.

Deutsche Bank Maintains Hold on Kimberly-Clark, Raises Price Target to $147

McCormick &amp; Company, Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mkc#NYSE">MKC</a>) reported solid third-quarter fiscal 2024 results, wherein the top and bottom lines beat the Zacks Consensus Estimate, and earnings increased year over year.
The company achieved a significant milestone by delivering overall global positive volume growth in the quarter, indicating improving trends across both business segments. The momentum is expected to carry into the fourth quarter. In the Consumer segment, MKC recorded solid volume growth despite facing a challenging macroeconomic environment in China. Meanwhile, in the Flavor Solutions segment, sequential volume improvements were realized, driven by strong growth in Branded Foodservice.
Management continues to bolster its position across major markets and core categories by focusing on growth levers such as brand marketing, product and packaging innovation, category management and proprietary technology. The company expects its cost-saving initiatives to help fund future investments and drive operating margin expansion. The year-to-date results, combined with strategic growth plans, reinforce confidence in achieving the mid-to-high range of projected sales growth for 2024.
<div class="chart_embed">
<h3>McCormick &amp; Company, Incorporated Price, Consensus and EPS Surprise 
<img alt="McCormick &amp; Company, Incorporated Price, Consensus and EPS Surprise" src="https://staticx-tuner.zacks.com/images/charts/ae/1727790166.png" style="height:265px; width:576px" title="" /></h3>
McCormick &amp; Company, Incorporated price-consensus-eps-surprise-chart | McCormick &amp; Company, Incorporated Quote
</div>
<h2>MKC&#39;s Quarterly Performance: Key Metrics and Insights</h2>
Adjusted earnings of 83 cents per share increased from 65 cents reported in the year-ago quarter. The metric came above the Zacks Consensus Estimate of 68 cents per share, representing a surprise of 22.1%. The year-over-year upside can be attributed to greater operating profit, the timing of a specific tax benefit and increased income from unconsolidated operations, fueled by robust performance from McCormick de Mexico, the company&#39;s largest joint venture.
This global leader in flavor generated sales of $1,679.8 million, flat year over year, including minimum impacts from currency movements. Impacts from the company&#39;s strategic decision to divest its canning business were offset by a 1% increase in volume backed by the Consumer segment, somewhat negated by pricing. The top line exceeded the Zacks Consensus Estimate of $1,664 million.
McCormick&#39;s gross profit margin expanded 170 basis points. The upside can be attributed to improved mix and cost savings from the Comprehensive Continuous Improvement&nbsp;program.
The adjusted operating income came in at $288 million, up 15% year over year, reflecting gross margin expansion and reduced SG&amp;A expenses.
<h2>Decoding MKC&#39;s Segmental Performance</h2>
Consumer: Sales remained flat year over year at $937.4 million, with a negligible impact on currency movements. Sales were hurt by a 1% decline from pricing actions, offset by 1% volume growth. Volume growth in the Americas and the Europe, Middle East, and Africa (&quot;EMEA&quot;) regions was partly negated by declines in the Asia-Pacific region (APAC). Sales remained flat year over year in the Americas while moving up 3% in the EMEA region. Segment sales dipped 1% in the APAC.
Flavor Solutions: Sales in the segment inched down 1% to $742.4 million. On a constant-currency basis, sales were flat year over year as a 1% rise in pricing was countered by the company&#39;s strategic move to sell off its canning business. Flavor Solutions&#39; sales in the Americas grew 2%. Flavor Solutions&#39; sales in the EMEA fell by 8%. Sales in the APAC market fell 1% year over year.
<h2>MKC&#39;s Financial Health Snapshot</h2>
McCormick exited the quarter with cash and cash equivalents of $200.8 million, long-term debt of $3,343.1 million and total shareholders&#39; equity of $5,451 million. In the nine months ended Aug. 31, 2024, net cash provided by operating activities was $463.2 million.
<h2>What to Expect From MKC in 2024?</h2>
For fiscal 2024, McCormick is focused on strengthening its volume trends and prioritizing investments to fuel profits. The company&#39;s CCI and Global Operating Effectiveness programs are driving growth investments and operating margin expansion. Management anticipates currency movements to have a minimal impact on 2024 results.
For 2024, management expects sales to range between a 1% decline and 1% growth, including minimal currency impacts. The company anticipates witnessing a favorable impact of pricing actions undertaken in the prior year. Volume trends are likely to improve due to solid brands and targeted investments. However, its decision to discontinue the low-margin business and sell the canning business is likely to put some pressure on volume during 2024.
Management expects adjusted operating income to grow 4-6%, including minimal currency impacts. This is likely to be driven by gross margin expansion, somewhat offset by a major rise in brand marketing investments.
Management envisions 2024 adjusted EPS in the band of $2.85-$2.90, which suggests a 5-7% increase from the year-ago period, including minimal currency impacts. On a GAAP basis, McCormick projects 2024 earnings in the range of $2.81- $2.86 per share compared with the year-ago period figure of $2.52.
This Zacks Rank #2 (Buy) stock has rallied 17.2% in the past three months compared with the industry&#39;s growth of 8.8%.
<h2>Other Top Staple Stocks</h2>
Here, we have highlighted three other top-ranked consumer staple stocks &mdash; The Chef&#39;s Warehouse (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/chef#NASDAQ">CHEF</a>), Flowers Foods (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/flo#NYSE">FLO</a>) and Kimberly-Clark Corporation&nbsp;(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/kmb#NYSE">KMB</a>).
The Chef&#39;s Warehouse, which engages in the distribution of specialty food products, currently sports a Zacks Rank #1 (Strong Buy).
CHEF has a trailing four-quarter earnings surprise of 33.7%, on average. The Zacks Consensus Estimate for The Chef&#39;s Warehouse&#39;s current fiscal year sales and earnings indicates growth of 9.7% and 12.6%, respectively, from the year-ago reported numbers.
Flowers Foods, one of the largest producers of packaged bakery foods in the United States, currently carries a Zacks Rank #2. FLO has a trailing four-quarter earnings surprise of 1.9%, on average.
The Zacks Consensus Estimate for Flowers Foods&#39; current financial-year sales and earnings implies growth of around 1% and 5%, respectively, from the year-ago reported numbers.
Kimberly-Clark is a personal care and consumer tissue product company that currently carries a Zacks Rank of 2.
The Zacks Consensus Estimate for Kimberly-Clark&#39;s current fiscal-year earnings indicates an advancement of 10.4% from the year-ago reported figure. KMB has a trailing four-quarter earnings surprise of 12.6%, on average.
<a href="https://www.zacks.com/stock/news/2344136/mccormick-q3-earnings-top-estimates-mkc-volumes-improve-y-y?cid=CS-BENZ-FT-analyst_blog|earnings_article-2344136">To read this article on Zacks.com click here.</a>

Management

CHEF

McCormick Q3 Earnings Top Estimates, MKC Volumes Improve Y/Y

Asset Sales

Global

Kimberly-Clark Is Said To Mull Options For International Tissue Business; Says Review At Early Stage, May Not Lead To Deal

<ul>
<li>New TCT agreements contribute to supporting America's clean energy transition through tax credit transferability under the Inflation Reduction Act (IRA).</li>
<li>Projects are helping to pave the way for additional investments from the voluntary market to support developers fostering renewable energy projects.</li>
<li>Through strategic guidance from Schneider Electric, Kimberly-Clark will fund four new battery energy storage projects, demonstrating its support of critical grid resiliency.</li>
</ul>
BOSTON, Sept. 23, 2024 /PRNewswire/ -- <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260781-1&amp;h=1845358604&amp;u=https%3A%2F%2Fwww.se.com%2Fus%2Fen%2F&amp;a=Schneider+Electric">Schneider Electric</a>,&nbsp;the global leader in the digital transformation of energy management and automation, today announced having facilitated several new TCT deals by <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260781-1&amp;h=3439761111&amp;u=https%3A%2F%2Fwww.kimberly-clark.com%2Fen-us&amp;a=Kimberly-Clark">Kimberly-Clark</a> Corporation, one of the world's leading manufacturers of personal care and hygiene products and owner of household brands such as Huggies, Kleenex, Scott, Kotex, Cottonelle, Poise, Depend, and WypAll.
Since 2016, Schneider Electric has served as a strategic advisor to Kimberly-Clark in the manufacturer's ambitious decarbonization goals. These include a commitment to reduce absolute GHG emissions by 50% (1) by 2030 and progressing towards 100% renewable electricity in North America by 2030.
Most recently, Schneider Electric acted as a strategic advisor to Kimberly-Clark to help fund multiple battery energy storage projects as part of the rapid energy transition to green America's grid. These TCT deals represent one of the many approaches Kimberly-Clark is taking to advance sustainable solutions. The projects also serve as leading examples of how the voluntary market can support developers fostering key projects using the IRA's new tax credit transferability mechanism.
The work on these collective projects supports the advancement of battery energy storage in the Texas, USA, region, aligned with Kimberly-Clark's support of the green transition in renewable energy storage and generation. Kimberly-Clark's current vPPAs produce clean power from wind in Texas, which makes up <a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4260781-1&amp;h=320883471&amp;u=https%3A%2F%2Fwww.epa.gov%2Fgreenpower%2Fgreen-power-partnership-national-top-100&amp;a=40%25+of+its+total+electricity+use+by+U.S.+operations+in+renewable+energy">40% of its total electricity use by U.S. operations in renewable energy</a> that Schneider Electric has advised on.
Details of the new Investment Tax Credit Transfer agreements include:
<ul>
<li>A $82.5M TCT agreement, a 180 MW battery energy storage facility</li>
<li>A $68M TCT agreement, a 100 MW battery energy storage facility</li>
<li>A $55M TCT agreement, a 100 MW battery energy storage project
<ul>
<li>A $32M TCT agreement, a 100MW battery energy storage facility</li>
</ul>
</li>
</ul>

Schneider Electric & Kimberly-Clark Announce Tax Credit Transfer Agreements To Advance Grid Resiliency

Wall Street Breakfast Podcast: Taiwan Semi Chips In Big Gains

Haleon: Guidance Implies Uncertainty Around Flu Season

Deutsche Bank lowered the firm's price target on Kimberly-Clark (KMB) to $140 from $143 and keeps a Hold rating on the shares. Looking to 2025, the...

Kimberly-Clark price target lowered to $140 from $143 at Deutsche Bank

The winds of uncertainty are shaking the foundation of economic optimism. From policy upheavals and global crises to the stubborn creep of inflation, growth prospects appear clouded. In this turbulent landscape, consumer staples, Walmart (WMT), Colgate-Palmolive (CL), and Kimberly-Clark (KMB), could provide a shield against market volatility. Continue to read… With President-elect Donald Trump's second term beginning in a month, a wave of uncertainties has been lingering in the U.S. economy. Despite geopolitical crises, incoming policy changes, and a slowly creeping rate of inflation, consumer staples remain a stable investment option, acting as a buffer against these uncertainties.
Hence, investors could scoop up shares of fundamentally stable consumer staple stocks Walmart Inc. (<a href="https://stocknews.com/stock/WMT/">WMT</a>), Colgate-Palmolive Company (<a href="https://stocknews.com/stock/CL/">CL</a>), and Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>) to look for steady returns in these uncertain times.
Trump's second term could begin with a bang, ushering in sweeping policy changes set to reshape global dynamics. His proposed <a href="https://abcnews.go.com/Business/trumps-proposed-tariffs-raise-prices-products-experts/story?id=115893557">60% tariffs on Chinese goods</a> and a pledged 25% tariff on Canadian imports within his initial days in office signal a storm brewing in the global trade landscape.
Adding to this upheaval, Trump's polarizing stance on <a href="https://www.brookings.edu/articles/how-is-trumps-reelection-likely-to-affect-us-foreign-policy/">the U.S.-Mexico border crisis</a> threatens to deepen rifts between the two nations. This tension is likely to ripple across business and trade networks, creating a precarious balance. His contrasting views on NATO, the Gulf situation, and climate change further fuel market uncertainty.
Inflation, stubbornly falling short of <a href="https://www.reuters.com/markets/us/us-consumer-spending-increases-solidly-october-inflation-stays-elevated-2024-11-27/">the Federal Reserve's 2% target</a>, compounds these concerns. Higher tariffs from the Trump administration could amplify costs, shrinking the scope for interest rate cuts next year. This tightrope walk leaves the U.S. economy exposed to unforeseen volatility.
Amid these shifts, consumer staples emerge as a silver lining. These essentials adhere to the principle of <a href="https://www.investopedia.com/terms/e/inelastic.asp">inelastic demand</a>, maintaining their stronghold even if costs climb. In turbulent economic waters, their consistent demand offers a haven for stability and smart investment.
So now, let us dive deep into the fundamentals of three consumer staples, starting with #3.
Stock #3: Walmart Inc. (<a href="https://stocknews.com/stock/WMT/">WMT</a>)
WMT is an omnichannel retailer that operates its business through retail, wholesale, other units, and eCommerce modes. The company has three segments: Walmart U.S.; Walmart International; and Sam's Club. It operates supercenters, supermarkets, hypermarkets, warehouse clubs, cash and carry stores, discount stores and others.
On December 3, Walmart <a href="https://corporate.walmart.com/news/2024/12/03/walmart-completes-acquisition-of-vizio">completed the $2.3 billion acquisition</a> of VIZIO, including its SmartCast operating system. With over 19 million active accounts, VIZIO's expanding device ecosystem strengthens WMT's ability to innovate customer experiences, leveraging smart TVs to elevate shopping convenience and engagement.
On November 21, WMT's Mexican division, Walmex announced the opening of its <a href="https://corporate.walmart.com/news/2024/11/21/walmart-de-mexico-y-centroamerica-celebrates-opening-of-2500th-bodega-aurrera">2500th Bodega Aurrera store</a> in Mexicali, Mexico. These store formats offer a wide range of products at affordable prices. This landmark opening would strengthen WMT's market presence in Mexico and boost its topline.
WMT's trailing-12-month <a href="https://www.investopedia.com/terms/r/roce.asp">ROCE</a> of 23.48% is 127.9% higher than the industry average of 10.31%. Its trailing-12-month ROTC of 11.49% is 65.3% higher than the sector average of 6.95%. Likewise, the stock's trailing-12-month asset turnover ratio of 2.58x is 201.5% higher than the industry average of 0.86x.
For the fiscal 2025 third quarter that ended October 31, 2024, WMT's total revenues increased 5.5% year-over-year to $169.59 billion. Its operating income rose 8.2% from the year-ago value to $6.71 billion. Additionally, consolidated net income attributable to WMT and adjusted EPS grew 910.4% and 850% from the prior year's quarter to $4.58 billion and $0.57, respectively.
Analysts expect WMT's revenue and EPS for the fiscal 2025 fourth quarter ending January 2025 to increase 4% and 6.8% year-over-year to $178.74 billion and $0.64, respectively. Moreover, the company topped the consensus revenue and EPS estimates in all four trailing quarters, which is impressive.
Shares of WMT have surged 42.3% over the past six months and 88.4% over the past year, closing the last trading session at $94.96.
WMT's <a href="https://stocknews.com/powr-ratings/">POWR Ratings</a> mirror its sound fundamentals. The stock has an overall rating of B, translating to a Buy in our proprietary rating system. The POWR Ratings are calculated by taking into account 118 different factors, with each factor weighted to an optimal degree.
WMT has an A grade for Stability and Sentiment and a B for Momentum. Within the A-rated <a href="https://stocknews.com/category/grocery-big-box-retailers/">Grocery/Big Box Retailers</a> industry, it is ranked #14 out of 36 stocks.
In addition to the POWR Ratings highlighted above, you can check WMT's ratings for Growth, Quality and Value <a href="https://stocknews.com/stock/WMT/">here</a>.
Stock #2: Colgate-Palmolive Company (<a href="https://stocknews.com/stock/CL/">CL</a>)
CL manufactures and sells consumer products. It works through two segments: Oral, Personal and Home Care; and Pet Nutrition. The company sells its products under various brands such as Colgate, Darlie, elmex, hello, meridol, Sorriso, Tom's of Maine, Irish Spring, Palmolive, Protex, and more.
CL's trailing-12-month gross profit margin of 60.42% is 67.1% higher than the industry average of 36.17%. Its trailing-12-month levered FCF margin of 14.82% is 165.9% higher than the sector average of 5.57%. Furthermore, the stock's trailing-12-month net income margin of 14.26% is 234.1% higher than the 4.27% industry average.
For the fiscal 2024 third quarter that ended September 30, CL's net sales increased 2.4% year-over-year to $5.03 billion. Its non-GAAP gross profit rose 7.1% from the year-ago value to $3.08 billion. Moreover, the company's non-GAAP operating profit increased 4.8% year-over-year to $1.08 billion.
Additionally, non-GAAP net income attributable to CL and non-GAAP EPS grew 5.6% and 5.8% from the prior year's quarter to $750 million and $0.91, respectively.
For the fiscal fourth quarter ending December 2024, Street expects CL's revenue and EPS to increase 1.9% and 3.4% year-over-year to $5.05 billion and $0.90, respectively. Additionally, the company topped the consensus revenue and EPS estimates in all four trailing quarters, which is noteworthy.
CL's shares have surged 5.3% over the past nine months and 19.5% over the past year to close the last trading session at $92.76.
CL's bright prospects are reflected in its POWR Ratings. The stock has an overall rating of B, which translates to a Buy in our proprietary rating system.
CL has an A grade for Quality and a B for Stability and Sentiment. It is ranked #14 out of 56 stocks in the <a href="https://stocknews.com/category/consumer-goods/">Consumer Goods</a> industry.
To access CL's Momentum, Growth and Value ratings <a href="https://stocknews.com/stock/CL/">click here</a>.
Stock #1: Kimberly-Clark Corporation (<a href="https://stocknews.com/stock/KMB/">KMB</a>)
KMB manufactures and markets personal care and consumer tissue products. The company has three segments: Personal Care; Consumer Tissue; and K-C Professional. It offers products under brands like Huggies, Pull-Ups, Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, and more.
On May 7, KMB's <a href="https://investor.kimberly-clark.com/2024-05-07-Kimtech-TM-Polaris-TM-Nitrile-Exam-Glove-Earns-ACT-Label-from-My-Green-Lab-R">Kimtech&#x2122; Polaris&#x2122; Nitrile Exam Glove</a> earned the Accountability, Consistency, and Transparency (ACT) Environmental Impact Factor Label from My Green Lab&#xAE;, the world's premier ecolabel for laboratory products. This development could increase the sales of KMB's gloves and boost its popularity in the laboratory equipment market.
KMB's trailing-12-month levered FCF margin of 12.41% is 122.6% higher than the industry average of 5.57%. Its trailing-12-month EBITDA margin of 19.39% is 48% higher than the 13.11% industry average. Additionally, the stock's trailing-12-month net income margin of 12.97% is 203.8% higher than the sector average of 4.27%.
For the fiscal third quarter that ended September 30, 2024, KMB's net sales came in at $4.95 billion. Its operating profit increased 49.1% year-over-year to $1.15 billion. Moreover, adjusted net income attributable to KMB and adjusted EPS rose 4.6% and 5.2% from the prior year's quarter to $617 million and $1.83, respectively.
KMB also increased its outlook for the fiscal 2024. The company expects a 3% to 4% growth in its organic net sales. Additionally, its adjusted operating profit and adjusted EPS are also expected to grow at a mid-to-high teens percentage rate on a constant-currency basis.
The consensus revenue estimate of $20.02 billion for the fiscal year ending December 2025 exhibits a marginal year-over-year rise. Its EPS for the same period is expected to rise 4.4% year-over-year to $7.64. Furthermore, the company surpassed the consensus EPS estimates in three of four trailing quarters.
Shares of KMB have surged 3% over the past nine months and 8% over the past year to close the last trading session at $130.61.
KMB's POWR Ratings reflect its robust prospects. The stock has an overall rating of B, equating to a Buy in our proprietary rating system.
KMB has a B grade for Quality, Value and Sentiment. it is ranked #7 out of 56 stocks in the Consumer Goods industry.
<a href="https://stocknews.com/stock/KMB/">Click here</a> to access KMB's ratings for Stability, Momentum, and Growth.
What To Do Next?
Get your hands on this special report with 3 low priced companies with tremendous upside potential even in today's volatile markets:
<a href="https://report.stocknews.com/free-report/3stocks/?formplacement=artbotad_3s">3 Stocks to DOUBLE This Year &gt;</a>
<hr />
WMT shares rose $0.19 (+0.20%) in premarket trading Thursday. Year-to-date, WMT has gained 82.46%, versus a 29.01% rise in the benchmark S&amp;P 500 index during the same period.
<hr><div style="clear:both;"></div> <h2>About the Author: Aanchal Sugandh</h2> <img src='https:/wp-content/uploads/2022/12/Aanchal-Sugandh_Headshot.jpg' style="float:left; padding:5px;width:125px;">Aanchal's passion for financial markets drives her work as an investment analyst and journalist. She earned her bachelor's degree in finance and is pursuing the CFA program.

She is proficient at assessing the long-term prospects of stocks with her fundamental analysis skills. Her goal is to help investors build portfolios with sustainable returns.<a href="https://stocknews.com/authors/?author=aanchal-sugandh">More...</a>The post <a href=https://stocknews.com/news/wmt-cl-kmb-3-consumer-staple-stocks-for-steady-returns-in-uncertain-times/>3 Consumer Staple Stocks for Steady Returns in Uncertain Times</a> appeared first on <a href=https://stocknews.com/>StockNews.com</a>

3 Consumer Staple Stocks for Steady Returns in Uncertain Times

Buy 6 December Dividend Kings But Watch 22 With 'Safer' Dividends

10 High-Yield Dividend Aristocrats For Growth And Bargain Hunters

Catalyst Watch: FOMC meeting, govt. funding drama, earnings for Micron, Nike, and FedEx

Honest Company's baby wipes face tariff-related risks - analyst

VDC: Consumer Staples Dashboard For December

AMZN

APLT

AVGO

BIRK

BTQQF

BUSE

CDUAF

CLBR

CLRB

CTAS

FCEL

GOEV

HLNCF

HNST

IDYA

IMPP

IONS

KVUE

LMND

LOVE

MDLZ

MSEX

NSRGF

NSRGY

PANW

PATK

PAYX

PECO

REAL

RECT

RSPS

SIMO

THFF

TROW

TSCO

USNA

VALE

VIVHY

VVVNF

Press Releases

Ten Teachers Named as First Prize Winners of the Heroes of the Classroom Program Presented by Kleenex®

Kimberly-Clark to Announce Third Quarter 2024 Financial Results on October 22, 2024

Huggies® Promotes Safe Sleep During Safe Sleep Awareness Month

Kimberly-Clark Announces Third Quarter 2024 Results and Reaffirms 2024 Profit Outlook

U by Kotex® Launches MaxiMalism Jeans to Help End Shame Around Periods

Lauren Brazel of Tinley Park High School Is Named the Grand Prize Winner of the Heroes of the Classroom Program Presented by Kleenex®

Kimberly-Clark Elects Joseph Romanelli to its Board of Directors

Dividends

Kimberly-Clark Declares Quarterly Dividend and Announces Date of 2024 Annual Shareholder Meeting

Kimberly-Clark to Webcast its Presentation at Morgan Stanley's Global Consumer & Retail Conference

KATHERINE HEIGL ADMITS TO A LITTLE "GIGGLE DRIBBLE" IN NEW POISE® CAMPAIGN THAT AIMS TO HELP NORMALIZE WOMEN'S BLADDER LEAKS

Comments

Kimberly-Clark

매도 수량

Kimberly-Clark (NYSE:KMB) 주식, 공매도 수량 보고

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌